INTRODUCTION
The basal tone in the internal anal sphincter (IAS) smooth muscle (SM) plays a critical role in the rectoanal incontinence (RI) (5, 22) , while intrinsic and extrinsic nerves in the IAS play an important role in the rectoanal inhibitory reflex-induced IAS relaxation, and modulation of the basal tone (6) . In addition, there are significant data to associate a decrease in the IAS tone with the increase in incidence of RI that occurs with aging in humans (2, 45) . Due in part to the lack of adequate knowledge of molecular mechanisms mediating basal IAS tone, there is no satisfactory therapeutic management of RI, or of motility disorders associated with IAS SM dysfunction (5, 34) .
Recent studies from our laboratory have focused extensively on uncovering mechanisms regulating basal IAS tone (28, 32) , and have ascribed an important role to the RhoA/ROCK pathway in regulating both animal and human IAS basal tone (30, 31) . RhoA/ROCK expression and related signal transduction cascade in the IAS SMCs are higher in comparison with that in the adjoining non-tonic SM (28, 31, 36) .
Activation of RhoA/ROCK causes phosphorylation of myosin-binding subunit of myosin light-chain phosphatase (p-MYPT1) leading to an increase in phosphorylation of regulatory myosin light-chain (p-MLC20) (3, 23, 29) , which in turn maintains smooth muscle tone.
In addition to the role of RhoA/ROCK in regulating basal tone, a compromise in the fibroelastic properties (FEP) of the IAS may also play a critical role in the incidence of RI during aging (16, 35, 40) .
Presently, there are no data on the pathophysiological mechanisms that regulate RhoA/ROCK and related signal transduction, or the FEP of the IAS during aging. It is conceivable that the basal tone and the FEP of the IAS may be regulated by changes in the extracellular matrix (ECM), including collagen and elastin.
Recent literature suggests that regulatory mechanisms effecting ECM expression, in multiple systems, are regulated by microRNAs (12, 27) .
We hypothesize that dysregulation of microRNAs in aging IAS plays a major role in decrease in the RhoA/ROCK-mediated IAS tone and compromise in the FEP of the IAS. To test this, we performed a genome-wide expression profile of miRNAs and computationally analyzed their target gene networks, and assessed the roles of different miRNAs in regulating contractility in the IAS from younger vs. older rats. We found that aging significantly up-regulates specific miRNAs in IAS resulting in down-regulation of target genes critical to the basal tone and FEP of the IAS. We identified a significant correlation between the expression pattern of the highly expressed miRs-199a-3p, -31-5p, -133a, -185-5p, -200b-3p
and miR-340-5p, known to target genes associated with fibrosis in older vs. young rats {13602, 13723, 13724, 13608, 13725, 13197}. Gain of function analysis of miR-133a in SM strips isolated from rat IAS further suggests that miR-133a negatively regulates contractile protein expression. Finally, we demonstrate that targeting miR-133a with anti-miRs in rat IAS reverses the age-associated loss of IAS tone. In conclusion, our findings identify miR-133a as an important determinant in the mechanistic regulation of IAS tone and that its dysregulation contributes to the decrease in the IAS tone that occurs with aging-associated RI.
MATERIALS AND METHODS

Gene expression microarrays.
mRNA microarrays. All studies were performed using IAS from Fischer rats (F344 of 6, 18, and 26 M old age groups provided by the National Institutes of Aging). The experimental protocols were approved by the Institutional Animal Care and Use Committee of Thomas Jefferson University.
Microarray analysis was performed as described previously (47) . Briefly, mRNA and miRNA fractions were isolated from the purified SMCs from the circular smooth muscle (CSM) layer of the IAS as previously described (36), by using miRVana miRNA Isolation kit following the manufacturer's protocol (8) . These studies were performed at Functional Genome Centre of Thomas Jefferson University.
Amplification of cDNA was performed from 50 ng RNA using the Ovation Pico WTA-system V2 RNA amplification system according to NuGen protocol (NuGen Technologies, Inc.). 5 μg cDNAs were fragmented and chemically labeled with biotin to generate biotinylated cDNA using FL-Ovation cDNA biotin module (NuGen Technologies, Inc.).
Affymetrix Gene Chips, rat gene 1.0 and 2.0 ST arrays (Santa Clara, CA), were hybridized with 5 μg fragmented and biotin-labeled cDNA in 220 μl of hybridization cocktail. Target denaturation was performed at 99°C for 2 min and then 45°C for 5 min, followed by hybridization for 18 h. Arrays were then washed and stained using Gene Chip Fluidic Station 450, using Affymetrix GeneChip hybridization wash and stain kit. Chips were scanned on an Affymetrix Gene Chip Scanner 3000, using Command Console Software.
Data were analyzed using GeneSpring software 11.5 (Agilent Technologies, Santa Clara, CA). Heat maps were generated from differentially expressed gene list, which was loaded into Ingenuity Pathway Analysis (IPA) 8.0 software (http://www.ingenuity.com) for biological network and functional analyses.
MicroRNA microarrays. miRNA microarray studies were performed as described previously (33, 43). Briefly, Affymetrix GeneChip miRNA Arrays were hybridized with Flash Tag biotin-labeled total RNA (500 ng) from experimental and control samples in 100 µl hybridization cocktail. Target denaturation was performed at 99 o C for 5 min. and then 45 o C for 5 min. followed by hybridization at 48 o C for 18 hrs. Arrays were washed and stained using Fluidic Station 450, and hybridization signals were amplified using antibody amplification with goat IgG and anti-streptavidin biotinylated antibody, followed by scanning as stated above. MiRNA data were analyzed by Affymetrix MiRNA QC tool and Genespring V 11.5 software using Robust Multichip Average (RMA).
Biological function and pathway analysis. Validation of differentially regulated miRNA and mRNA from genome-wide microarray.
Quantitative reverse transcription (RT)-PCR (qRT-PCR or qPCR).
We performed qPCR by using cDNA synthesis kit, SYBR Green RT-PCR Kit (Qiagen) and genespecific primers ( Details of adapted procedure for the perianal injections have been described previously (13) . For these injections we used microneedle (31-gauge) attached to 300µl insulin syringe.
Both intraluminal manometry and perianal injection procedures were carried out under isoflurane inhalation anesthesia (initially with 5% isoflurane and then maintained with 1 % isoflurane throughout the length of the experiment).
Statistical analyses. miRNA microarray data were verified by a close correlation between qPCR and microarray via linear regression analysis. qPCR data for mRNA and miRNA was replicated further on four to six rats in different experiments. Genes showing gradient of expression in 6 M vs 26 M old rats were selected for miRNA target analysis. Comparison between 2 groups was analyzed using the 2-tailed Student's t test; and comparison between multiple groups was made using one-way ANOVA and Newman-Keuls posttest using GraphPad Prism 5.0. Data are presented as the mean ± SEM.
RESULTS
Differential gene expression during aging in IAS smooth muscle.
Genome-wide expression profiles via microarray on the total RNA of the IAS SMCs from three groups of rats, 6, 18, and 26 MO employed Affymetrix rat Gene Chips 1.0 and 2.0. These chips probed for 27,342 and 29,489 sets of genes, respectively. 6 M rats served as control or reference point to determine up-and downregulation of gene transcripts. All unknown transcripts (without known gene name and ID) and transcripts with weak signal intensity (below 50) were ignored. Only the transcripts with noticeable gradient for up or down-regulation between 6, 18 and 26 M age groups were considered. These transcripts were clustered into groups by biological function. We applied hierarchical clustering (Pearson correlation) to the expression profiles of differentially expressed transcripts in the IAS SMCs from younger vs. older rats to determine patterns in the data. These results are presented as a heat map and dendrogram ( Figure 1A) . A striking finding was a significant down-regulation of genes known to be involved in SM contractile phenotype (Myocd) and those in the basal tone of IAS (RhoA), in the IAS of older vs. younger rats.
Relevant functions and pathways in IAS smooth muscle of aged rat. IPA (25) identified a number of significantly differentially expressed genes in IAS SM during aging. One of the pathways that showed the highest differential gene expression was found to be RhoA/ROCK signaling pathway.
Significant IPA canonical pathways and the associated molecules are presented in Supporting Figure S1 . The relative expression of these genes from these samples is shown in Figures 1B (mRNA) and Figure 2B (protein). PCR and WB bands are given in Figure 2A .
Differential down-regulation of these genes plus up-regulation of Rgs2 in IAS SMCs of 26 M vs. the younger rats was further confirmed by immunofluorescence studies ( Figure 3A , B, C). Because initial comparison of mRNA and mi-RNA arrays and validations studies between 6, 18, and 26 month age groups revealed most significant and consistent differences in the 26 M vs. 6 M groups, immunofluorescence and other detailed studies were performed in these age groups only.
Differential miRNA expression during aging in IAS smooth muscle. Affymetrix miRNA Expression Profiling Assay system in IAS from 6, 18 and 26 months rats identified marked differential expression of a number of miRNAs as shown as a heat map in Figure 4A . All mRNA and miRNA microarray data were deposited in the Gene Expression Omnibus (GEO) database and can be accessed as http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE79348.
The correlation between miRNAs microarray and qPCR data was confirmed by regression analysis of low and high-expressing miRNAs ( Figures 4B, and 4C , respectively).
Based upon this analysis we selected miRNAs targeting RhoA directly, and other signaling molecules regulating RhoA expression indirectly ( Figure 4D ).
qPCR analysis confirmed that miR-1, miR-133a-3p, miR-185-5p, miR-199a, and miR-200b-3p, were significantly up-regulated in IAS SMCs from 26 MO rats (n = 4; P < 0.05; Figure 4E ). These results demonstrate that miRNA-133a reduces the IAS tone not only in the basal state but also in the stimulated state, both involving RhoA/ROCK pathway ( Figure 6B ).
Rescuing effect of anti-microRNA inhibitor on aging-associated decease in IASP.
In agreement with above in vitro data, in vivo studies revealed significantly (*; p < 0.0; n = 3; Figure 6C) reduced IASP in aging rats. To further implicate miR-133a in the age-associated decrease in IASP, studies in Figure 6C demonstrate that perianal injections of anti-miR-133a into IAS significantly rescued the loss of IASP 48h and 72 h post injection both in males and females (**; P < 0.05; n = 3 animals of each age and sex group). These recusant effects as determined at 72 h were found to be statistically significant and similar both in male and female rats.
DISCUSSION
In the present study we performed a high throughput screening involving microarray and the genomewide transcriptome analysis to gain insight into miRNA-dependent regulatory mechanisms that influence age-related differences in IAS tone. We identified 22 genes that are down-regulated in IAS smooth muscle from older rats, including Myocd, SRF, RhoA and ROCK2 which are known important regulators of SM differentiation and contractility. In parallel, a comprehensive screening identified eleven microRNAs that are significantly up-regulated in the aging IAS SM. Subsequent bioinformatics analysis combined with pathway analysis and predicted targets led to the conclusion that miR-133a downregulates RhoA/ROCK2, MYOCD and SRF.
The present study also identified significant changes related to age in the SM signaling transduction (4, 12, 24) . In the present study, using mRNA and miRNA microarrays followed by bioinformatics analyses, we identified differentially expressed mRNA and miRNAs, in the rat IAS SM.
Earlier studies attempting to understand the regulation of basal IAS tone, and its decrease during aging, have shown the critical role of RhoA/ROCK pathway in animals and humans (29, 30, 32, 35) . A number of genomic, proteomic and functional studies have documented miR-133a can target RhoA {13197, 13756, 13649}, a major upstream trigger for the downstream signal transduction cascade for the sustained SM tone (23, 29, 32) . To determine the effect of miR-133a on SM contractile proteins expression, we overexpressed miRNA-133a in rat IAS SMC. This overexpression decreased the endogenous protein levels of two markers of myogenic determination, myocardin and SRF, whereas inhibition of the endogenous miR-133a by antagomir-133a resulted in the up-regulation of these proteins (data not shown). This is in agreement with previous studies in which manipulating miR-133a levels in other tissue types showed a significant reduction in contractile proteins expression (44) implicating miR-133 as a regulator of muscle differentiation (50).
Myocardin is a master regulator of SMC differentiation and contractile phenotype, and its negative regulation by miRs-143/145, and 204/211 induces SMC synthetic phenotype differentiation (7, 12, 52) .
The development of SM is a well-coordinated process of cell proliferation, differentiation and migration that is regulated by evolutionarily conserved networks of myogenic transcription factors (48, 52) . The maintenance of a SM contractile phenotype requires a fine balance between the expression and the repression of many genes (19) .
The current study demonstrates for the first time that miR-133a is up-regulated in aging IAS SM and its overexpression inhibits the basal tone and agonist-induced contraction. Previous studies have demonstrated that aging reduces the basal IAS tone (35) that has been associated with the downregulation of RhoA/ROCK2. Although the mechanism of down-regulation of RhoA and ROCK2 in IAS SM during aging is not fully understood, present data suggest that miRNA-133a is an important factor in that regard.
Present data demonstrate a direct relationship between the changes in miRNA and changes in mRNA expression in the IAS SM from different age groups, especially in 26 M vs. 6 M. In addition, miRNA133a is up-regulated in the IAS from aged rat and the overexpression of miRNA-133a mimics the agingassociated decrease in the IAS tone in basal as well as stimulated state by RhoA/ROCK activator U46619 (15, 41) . These findings have significant relevance in the pathophysiology and potential reversal of agingassociated IAS dysfunction, via miRNAs intervention. We speculate that aging-associated RI (especially characterized by the hypotensive IAS), is in part associated with by changes in expression profile of miRs, which may be reversed by the respective antagomirs or miRs. Conversely, down-regulation of miR-133a may lead to anorectal motility disorders characterized by hypertensive IAS (e.g. recurrent anal fissures and hemorrhoids), potentially reversible by overexpression of miR-133a using appropriate oliogmiR. Our data clearly show that reduced IASP observed in aging rats is reversible by anti-miR-133a both in male and female rats.
The present data contribute significantly to our current understanding of the role of miRNAs in the regulation of SM contractility and differentiation (26, 38) . However, the effects of aging on the expression of miRNA-133a, and the associated functional consequences, appear to be system-/cell typedependent. For example, studies have implicated decreases in the levels of miRNA-133a in the arterial SMCs from patients with arteriosclerosis obliterans (ASO), a common occurrence in the aging population (17) . In contrast, aging has been shown to have opposite effects, i.e., an increase in the levels of miRNA133a in human skeletal muscle (11) . Regardless, it is well known that miRNA-133a negatively regulates
RhoA; downregulation of miR-133a promotes the proliferation, migration, and contraction, while its upregulation has the opposite effect, by targeting RhoA (9, 17) .
In summary, this work identifies the role of miRNAs in the regulation of IAS smooth muscle basal tone and agonist-induced contraction. Data reveal a significant impairment in myogenic factor and contractile proteins expression due to miRNA/mRNA interaction with aging. These data provide strong evidence for dysregulated miRNA as a key factor in the compromise of SM plasticity with age, and in pathogenic mechanisms associated with RI. This constitutes the first study to demonstrate that miRNA133a and its gene targets are crucial to RhoA signaling pathway in relation to contractility, and IAS SM phenotype in the aging. We speculate that the basal tone and the FEP of the IAS are regulated by changes in the transduction molecules, growth and transcription factors, regulators of SMCs differentiation, ECM components, and early markers of SMCs via microRNA-targeting diverse signaling pathways.
Collectively, present data identify miR-133a as a potential target for therapeutic application in agingassociated RI with compromise in the IAS basal tone and biomechanics. by 60 nM miR-133a is significantly blocked by 60 nM antagomirs (**; P < 0.05; n = 4). B. miR-133a significantly shifts U46619 CRC of increase in the IAS tone towards right (*; P < 0.05; n = 6-8). The latter is blocked by the antagomirs pre-treatment so that U46619 CRC in the presence of 60 nM of miR133a + antimiR is not significantly different from control (P > 0.05; n = 6-8). C. Perianal injection of anti-miR-133a significantly (**; P < 0.05) rescues the decreased (*; P < 0.05) IASP during aging in 26 M rats as compared with their corresponding 6 M both in males and females (n = 6 animals, three males and three females used for each animal group). The rescuing effect was found to be sustained for up to 72
hours following the injection of the anti-miR, both in males and females.
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